Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Lipid-lowering drugs save lives, but use decreasing
Dec 01, 2023
In 2019 to 2020, 56% of patients with high cholesterol were on statins for primary prevention and 85% were on them for secondary prevention.
Acute hospital care at home shows promise for medically complex patients
Jan 08, 2024
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
Burden of heart disease considerable for American Indians, Alaska Natives
Sep 26, 2023
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.
AI’s latest benefits extend from a wheelchair to cardiac care, health experts tout
By
Aaron Dorman
Feb 28, 2024
AI is now able to diagnose a specific kind of heart failure, HFpEF, and can improve wheelchair mobility, according to a new report.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
NIA start-up grant winner includes AI-chatbot for pain management
By
Aaron Dorman
Feb 29, 2024
An NIA grant program is funding a new start-up that uses conversational AI to address seniors’ pain concerns.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Light therapy innovations help sustain a light heart, benefit circulatory conditions, too
By
Aaron Dorman
Mar 18, 2024
The benefits of chronologically timed light therapy now extend to lowering the risk for heart disease, a new study shows.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.